These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3432148)

  • 1. [The role of endogenous digoxin-like substance in the pathogenesis of arterial hypertension in pregnancy].
    Soszyński P; Słowińska-Srzednicka J; Latoszewska-Smółko W
    Pol Tyg Lek; 1987 Sep; 42(37):1145-8. PubMed ID: 3432148
    [No Abstract]   [Full Text] [Related]  

  • 2. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
    Graves SW; Lincoln K; Cook SL; Seely EW
    Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin-like immunoreactive factor in twin and pregnancy-associated hypertensive pregnancies.
    Jakobi P; Krivoy N; Weissman A; Paldi E
    Obstet Gynecol; 1989 Jul; 74(1):29-33. PubMed ID: 2733937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy-induced hypertension.
    Kaminski K; Rechberger T
    Am J Obstet Gynecol; 1991 Sep; 165(3):733-6. PubMed ID: 1892203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactive factor in twin and pregnancy-associated hypertensive pregnancies.
    Goodlin RC
    Obstet Gynecol; 1989 Dec; 74(6):974-6. PubMed ID: 2586967
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in plasma and urinary digoxin-immunoreactive like substance in normal pregnancy and pregnancy-induced hypertensive women].
    Li AQ; Zhang ZJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):133-5, 187. PubMed ID: 8354089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of endogenous digitalis-like substances in patients with pregnancy-induced hypertension].
    Gao SS; Chen ZQ; Xu YQ
    Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):299-302, 326-7. PubMed ID: 7953923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular investigations of an endogenous digoxin-like factor.
    Gruber KA; Metzler CH; Robinson TE; Buggy J; Bullock BC; Lymangrover JR
    Fed Proc; 1985 Sep; 44(12):2795-9. PubMed ID: 2411606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endogenous digoxin-like substance level in essential arterial hypertension, renal failure and acromegaly].
    Soszyński P; Słowińska-Srzednicka J; Wierzbicki M
    Pol Arch Med Wewn; 1988 Jan; 79(1):20-5. PubMed ID: 3275165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between umbilical artery and vein endogenous digoxin-like immuno-active factor levels in normal and pre-eclamptic patients.
    Schabort I; Odendaal HJ; Lombard CJ; Bredell L
    S Afr Med J; 1991 Feb; 79(4):197-9. PubMed ID: 1996437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of an endogenous digitalis-like substance in the development of hypertension].
    Morise T; Takeda R
    Nihon Rinsho; 1989 Sep; 47(9):1973-8. PubMed ID: 2593272
    [No Abstract]   [Full Text] [Related]  

  • 12. [Digoxin-like natriuretic factor, raised during normal pregnancy, is increased in pregnancy-induced hypertension and pre-eclampsia].
    Fiévet P; el-Esper N; Roth O; Siegenthaler G; Grégoire I; Favre H; Fournier A
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):942-6. PubMed ID: 2959238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endogenous digitalis-like substance. II. Relation to pathologic states and diseases].
    Martinka E
    Vnitr Lek; 1995 Oct; 41(10):719-23. PubMed ID: 8578707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous digoxin-like immunoreactivity during pregnancy and at birth.
    Lupoglazoff JM; Jacqz-Aigrain E; Guyot B; Chappey O; Blot P
    Br J Clin Pharmacol; 1993 Mar; 35(3):251-4. PubMed ID: 8471401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous digoxin-immunoactive factor in human subjects.
    Valdes R
    Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal endoxins and complications of pregnancy.
    Goodlin RC; Makowski EL
    West J Med; 1988 May; 148(5):590-2. PubMed ID: 2845675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy.
    Yurdakök M; Oran O; Tekinalp G; Göktoğan S
    Turk J Pediatr; 1989; 31(4):271-3. PubMed ID: 2486426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin-like immunoreactivity in human body fluids.
    Clerico A; Del Chicca MG; Montereggi A; Balzan S; Ghione S
    J Nucl Med Allied Sci; 1985; 29(4):305-12. PubMed ID: 3012031
    [No Abstract]   [Full Text] [Related]  

  • 20. A ouabain-displacing factor in normal pregnancy, pregnancy-induced hypertension and pre-eclampsia.
    Gregoire I; Roth D; Siegenthaler G; Fievet P; el Esper N; Favre H; Fournier A
    Clin Sci (Lond); 1988 Mar; 74(3):307-10. PubMed ID: 2831007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.